Both in Pharmaceuticals
First Tracks Biotherapeutics vs Zenas BioPharma
Over the past year TRAX returned +24.3% and ZBIO returned −7.9%; their daily moves had a correlation of 0.45.
TRAX +24.3% ZBIO −7.9%Growth of $1, one year, split-adjusted
| Metric | TRAX | ZBIO |
|---|---|---|
| Price | $45.29 | $28.67 |
| Market cap | $1.90B | $1.87B |
| Today | −0.94% | −0.35% |
| 1 month | +27.8% | +6.3% |
| 6 months | — | +48.4% |
| Year to date | — | −21.0% |
| 1 year | — | −5.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −11145.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 1,868.6× |
| Net cash | $168.0M | $346.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 55.5% |
| Short % of float | 21.3% | 40.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).